2012 Forecast for US Molecular Diagnostics Market Now Available From Global Information Inc.
FARMINGTON, Conn., April 16, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce two significant new developments in biotechnology and biomarker market research with the release of the Venture Planning Group's annual survey of the US molecular diagnostics market, available immediately, and remaining limited registration for the Biomarker World Congress in Philadelphia in May.
The 2012 US Molecular Diagnostics Market
The Venture Planning Group has released the 2012 edition of their annual report on the state of the US molecular diagnostics market. Spanning 880 pages and including 37 tables of data, this market research report presents a comprehensive analysis of the US molecular diagnostics market, including major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
Buyers will also gain access to an extensive review of DNA probe and biochip technologies, test formats, detection methodologies, and trends in testing automation and amplification methods. The report highlights ten-year test volume and reagent sales forecasts in the categories of infectious diseases, genetic diseases, cancer, paternity testing, HLA typing, and forensic testing. Also, the topics of testing methodologies and instrumentation technologies, as well as a feature comparison of automated and semiautomated analyzers and sales and market shares of leading suppliers are all compiled. In sum, over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products are discussed.
An Executive Summary of this research and a free sample of the full report are available at http://www.giiresearch.com/report/vpg224815-future-us-molecular-diagnostics-market-growth.html
8th Annual Biomarker World Congress
Professionals invested in the biomarkers market will find significant value in the Cambridge Health Institute's 8th annual Biomarker World Congress in Philadelphia, PA May 21-23, 2012. Join hundreds of biotechnology peers to network, exchange knowledge, and discuss developments with a distinguished faculty of over 40 professionals across four different tracks, Biomarkers in Drug Development, Molecular Diagnostics, Biomarker Assay Development, and Executive Summit: Drug-Diagnostic Co-Development.
Additional information is available at http://www.giiconference.com/chi214653-2012/
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States
SOURCE Global Information Inc.